Prostate Cancer News: Breaking Prostate Cancer News, Comments and Articles.

Men With Afflicted Illnesses Must Know What to Expect from Prostate Surgeries while Dr. Allen’s Device Reverses BPH Naturally, Highlights Fine Treatment

Researchers have found that men with slower-growing forms of cancer and with three or more other serious illnesses, such as heart disease, diabetes, and hypertension, are far more likely to die from one of those illnesses than from their prostate cancer, and recommend avoiding debilitating conventional treatment options. Fortunately, Dr. Allen’s Device treats non-malignant prostate enlargement (...

Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same

Dennis R. HIll M.D. Radiation Oncologist at the Alta Bates Summit Medical Center in Oakland, CA continues his series of discussions on comparing the latest in prostate cancer treatment options. Oakland, CA (PRWEB) May 25, 2013 Dennis R. HIll M.D. Radiation Oncologist at the Alta Bates Summit Medical Center in Oakland, CA reports that recently there has been a promotion of the idea that a newer is...

The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients

Astellas submits Japan application for enzalutamide

Astellas Pharma Inc. (Tokyo:4503) and Medivation Inc. (NASDAQ:MDVN) said the pharma submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for enzalutamide to treat prostate cancer. FDA approved the oral androgen r...

Astellas and Medivation file for approval of enzalutamide in Japan

Japanese drug major Astellas Pharma (TYO: 4503) has submitted an application for marketing approval of enzalutamide to the Ministry of Health, Labor and Welfare in Japan for the treatment of prostate cancer.

'We Need to Raise the Bar' on Prostate Surgeries

Dr. Matthew Cooperberg talks with Andrew Vickers about new research tying high-volume surgeons and hospitals to better outcomes in prostate cancer surgery. Medscape Urology

Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan

Astellas Pharma Inc. (TOKYO: 4503) and Medivation, Inc. (NASDAQ: MDVN) today announced that Astellas has submitted an application for marketing approval of enzalutamide (generic name) to the Ministry of Health, Labour and Welfare in Japan for the treatment of prostate cancer. Enzalutamide is a novel, once-daily, oral androgen receptor signaling in...

Astellas seeks Japan approval of Xtandi

Following a go-ahead for marketing approval in the EU last month, Medivation's novel prostate cancer drug enzalutamide has been filed for approval in Japan by ex-US global licensee Astellas. The once-daily oral androgen receptor.....

Astellas submits application for marketing approval of enzalutamide for prostate cancer

Astellas Pharma Inc. and Medivation, Inc. today announced that Astellas has submitted an application for marketing approval of enzalutamide (generic name) to the Ministry of Health, Labour and Welfare in Japan for the treatment of prostate cancer.

Men Can Expect Recovery from Chronic Prostatitis with Dr. Allen’s Device While Recent Customer Letters Confirm that Antibiotics are Helpless, Highlights Fine Treatment

Recent messages from men, like “I have been suffering for the past 3 years, tried all sorts of antibiotics,” or “I have been suffering from the last 1 year. I have had antibiotics but still the problem persists,” show that urologist should reconsider the treatment plan for patients with chronic prostatitis and Dr. Allen’s is able to help up to full recovery, depending on the stage of thi...

Researchers use data to identify different forms of prostate cancers and effective treatment options

Some prostate cancer patients unnecessarily undergo surgery or harsh treatments because science fails to identify the differences between slow-growing and aggressive forms of the disease. Researchers at Case Western Reserve University and Johns Hopki...

Some aggressive forms of prostate cancer have similar genetic origins

Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings appear online today in...

Researchers explore targeted therapies for prostate cancer

Are certain drugs more effective against some types of prostate cancers than others? Researchers know that not all therapies work for all patients – the next question is to figure out how to match the right treatments with the right patients.

SonaCare Medical highlights need for image-guided technologies to better identify prostate cancer

The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108th Annual Meeting of the American Urological Association, in San Diego.

Inexpensive, Accurate Way To Detect Prostate Cancer Could Facilitate Commercially Available, At-Home Urine Tests

Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published in the /iJournal of the American Chemical Society. After more than a decade of work, UC Irvine chemist...

Study Clarifies Roles Of Anti-Angiogenic Proteins In Discouraging Metastasis And Reveals Potential Anti-Metastasis Drug

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse...

Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial

The firm is currently offering da Vinci robot lawsuit evaluations to those who have suffered serious da Vinci surgery complications during robotic surgery procedures. (PRWEB) May 23, 2013 Da Vinci surgical robot maker Intuitive Surgical defeated negligent training claims in a trial in Washington State May 23, according to Bloomberg.* The Rottenstein Law Group LLP, which represents clients in surg...

Local insulin-like growth factor-I of ventral prostate was upregulated during long-term castration and may function through the autocrine system

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

[EDAP TMS] nets $11.4mm through registered direct ADS offering

[EDAP TMS SA] (high-intensity focused ultrasound for prostate cancer, and lithotripsy for urinary tract stones) netted $11.4mm through the registered direct offering of 3mm ordinary shares in the form of American Depositary Shares (ADSs) at $4, a 6%...

Patients Honor Dr. Ricardo R. Gonzalez for Compassion

HOUSTON, May 23, 2013 /PRNewswire-USNewswire/ -- Patients' Choice has announced that Dr. Ricardo R. Gonzalez was one of a select few physicians honored with the prestigious 2012 Compassionate Doctor Certification. (Photo:  http://photos.prnewswire.com/prnh/20130523/DC20137) Each year, nearly 100 million patients across the U.S. access websites like Vitals, UCompareHealthCare, and Patients...

Genomic analysis lends insight to prostate cancer

Researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression.

Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting

SAN DIEGO, May 23, 2013 /PRNewswire/ -- The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108th Annual Meeting of the American Urological Association (AUA), in San Diego.  According to SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, the need for image-guided techn...

Aggressive Prostate Cancer Treatment Not Needed in Older Men

Older men with newly diagnosed localized prostate cancer, especially those with other serious health conditions, are unlikely to derive benefit from aggressive treatment. Medscape Medical News

Clinical trial tests targeting prostate cancer treatment

ANN ARBOR, Mich., May 23, 2013 /PRNewswire-USNewswire/ -- Are certain drugs more effective against some types of prostate cancers than others? Researchers know that not all therapies work for all patients – the next question is to figure out how to match the right treatments with the right patients. A new clinical trial is testing whether targeting treatments to a genetic anomaly can l...